awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38083041-176D26EC-106B-40E4-A214-A237DEB9DB5E
Q38083041-176D26EC-106B-40E4-A214-A237DEB9DB5E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38083041-176D26EC-106B-40E4-A214-A237DEB9DB5E
Immunotherapy of multiple sclerosis: the state of the art.
P2860
Q38083041-176D26EC-106B-40E4-A214-A237DEB9DB5E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38083041-176D26EC-106B-40E4-A214-A237DEB9DB5E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a32894a6780d81712c99266b9ab5436bf935bef
P2860
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.